686 related articles for article (PubMed ID: 10627749)
1. [25 years of gastric acid blockers].
Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
[TBL] [Abstract][Full Text] [Related]
2. Drug therapy of peptic ulcer disease.
Ching CK; Lam SK
Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
4. [Omeprazole in the therapy of acid-induced diseases].
Simon B; Dammann HG; Müller P
Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
[TBL] [Abstract][Full Text] [Related]
5. Powerful gastric acid inhibition: when is it justified?
Dobrilla G; Amplatz S
Ital J Gastroenterol; 1990; 22 Suppl 1():13-7. PubMed ID: 1983420
[TBL] [Abstract][Full Text] [Related]
6. [Lansoprazol ++ : a new proton pump inhibitor].
Baczek J; Laskowiec G
Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021
[TBL] [Abstract][Full Text] [Related]
7. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
Bown RL
Int J Clin Pract; 2002 Mar; 56(2):132-9. PubMed ID: 11926700
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
9. Drugs for treatment of peptic ulcers.
Dajani EZ; Trotman BW
J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
[TBL] [Abstract][Full Text] [Related]
10. Gastric acid suppressants--too much of a good thing?
Logan IC; Sumukadas D; Witham MD
Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
[No Abstract] [Full Text] [Related]
11. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
Clissold SP; Campoli-Richards DM
Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
[TBL] [Abstract][Full Text] [Related]
12. Acid pump blockers: what are their current therapeutic roles?
Arens MJ; Dent J
Baillieres Clin Gastroenterol; 1993 Mar; 7(1):95-128. PubMed ID: 8097414
[No Abstract] [Full Text] [Related]
13. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology].
Carella G
Clin Ter; 1984 Mar; 108(6):525-9. PubMed ID: 6144411
[No Abstract] [Full Text] [Related]
14. H2-receptor antagonists in perspective.
Malagelada JR; Cortot A
Mayo Clin Proc; 1978 Mar; 53(3):184-90. PubMed ID: 24155
[TBL] [Abstract][Full Text] [Related]
15. Omeprazole: a new approach to gastric acid suppression.
Buhl K; Clearfield HR
Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
[TBL] [Abstract][Full Text] [Related]
16. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A
Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238
[No Abstract] [Full Text] [Related]
17. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
Leite LP; Just RJ; Castell DO; Lagerström PO
Am J Gastroenterol; 1995 Oct; 90(10):1874-7. PubMed ID: 7572913
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with omeprazole: assessment of efficacy and safety.
Walan A
J Gastroenterol Hepatol; 1989; 4 Suppl 2():27-33. PubMed ID: 2491359
[TBL] [Abstract][Full Text] [Related]
19. H2 receptor antagonists.
Siepler JK; Campagna KD; Donahue PE; Bombeck CT
Am J Hosp Pharm; 1978 Feb; 35(2):141-5. PubMed ID: 24338
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility and safety of omeprazole.
Walan A
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():107-11. PubMed ID: 2657279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
